Search results for "Ladder"

showing 10 items of 674 documents

Cizolirtine Citrate, an Effective Treatment for Symptomatic Patients with Urinary Incontinence Secondary to Overactive Bladder: A Pilot Dose-Finding …

2009

Abstract Background A dose-finding study was performed as the first step in the clinical development of the new drug, cizolirtine citrate. Objective To assess the efficacy and safety of cizolirtine citrate in overactive bladder with urinary incontinence. Design, setting, and participants Seventy-nine outpatients with clinical overactive bladder and/or urodynamic diagnosis of detrusor overactivity were randomized in a multicentre, 12-wk, double-blind, pilot trial. Interventions Patients received cizolirtine citrate 400mg bid (C400), cizolirtine citrate 200mg bid (C200), or placebo. Measurements Patients recorded efficacy variables in 7- and 14-d bladder diaries: urinary incontinence episodes…

Adultmedicine.medical_specialtyVomitingCalcitonin Gene-Related PeptideUrologyUrinary systemVision DisordersUrologyPilot ProjectsUrinary incontinenceSubstance PPlaceboDizzinesslaw.inventionYoung AdultDouble-Blind MethodRandomized controlled triallawmedicineHumansAdverse effectAgedAged 80 and overUrinary bladderDose-Response Relationship DrugUrinary Bladder Overactivebusiness.industryNauseaMiddle Agedmedicine.diseaseUrodynamicsUrinary Incontinencemedicine.anatomical_structureTolerabilityOveractive bladderPyrazolesFemalemedicine.symptombusinessEuropean Urology
researchProduct

Mitomycin C from birth to adulthood.

2016

Mitomycin C (MMC) intravesical therapy for “superficial” papillary bladder tumors was firstly introduced in the early seventies with promising results. In the following years, several pharmacokinetic studies investigated its mechanism of action to optimize the intravesical administration. Numerous studies confirmed thereafter both the ablative and the prophylactic efficacy and the low toxicity of MMC when intravesically given. In 1984, a complete response rate of 42% in 60 patients not responsive to thiotepa was reported with intravesical MMC at the dose of 40 mg diluted in 40 ml for 8 weeks. In the following decades, many large randomized studies showed the benefit of intravesical prophyla…

Adultmedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentMitomycinAntibiotics030232 urology & nephrologyUrologyThioTEPASettore MED/24 - Urologia03 medical and health sciencesYoung Adult0302 clinical medicinePharmacokineticsMedicineHumansYoung adultChildComplete responseAntibiotics Antineoplasticbusiness.industryMedicine (all)digestive oral and skin physiologyMitomycin CGeneral MedicineRegimenUrinary Bladder Neoplasms030220 oncology & carcinogenesisUrinary Bladder NeoplasmbusinessAdjuvantHumanmedicine.drugUrologia
researchProduct

A New Systematic Classification of Peripheral Anatomy of the Right Hepatic Duct: Experience From Adult Live Liver Donor Transplantation

2008

Abstract Objective The peripheral intrahepatic biliary anatomy, especially at the sectorial level on the right side, has not been adequately described. The purpose of our study was to systematically describe this complex anatomy in clinically applicable fashion. Patients and Methods We analyzed three-dimensional computed tomography (CT) imaging reconstructions of 139 potential living liver donors evaluated at our institution between January 2003 and June 2007. Results Eighty-nine (64%) donors had a normal right bile duct sectorial anatomy. In the other 50/139 (36%) cases, we observed abnormal sectorial branching patterns, with 45/50 abnormalities as trifurcations, whereas the remaining ones…

Adultmedicine.medical_treatmentHepatic Duct CommonLiver transplantationAnastomosisFunctional LateralityCholangiographyImage Processing Computer-AssistedLiving DonorsmedicineHumansSurvivorsTransplantationmedicine.diagnostic_testBile ductbusiness.industryGallbladderAnastomosis SurgicalGallbladderAnatomyLobeCholecystographyLiver TransplantationSurvival RateTransplantationmedicine.anatomical_structureSurgeryBile DuctsHepatectomyTomography X-Ray ComputedbusinessCholangiographyTransplantation Proceedings
researchProduct

Inhibition of human detrusor contraction by a urothelium derived factor.

2003

Stimulating muscarinic receptors in pig bladder urothelium causes the release of a diffusable factor that inhibits contractions of the underlying detrusor muscle. We investigated whether the contractions of human detrusor strips elicited by the muscarinic agonist carbachol, electrical field stimulation, KCl or the neurokinin receptor agonist neurokinin A are affected by the urothelium.Paired intact and urothelium denuded muscle strips were placed in modified gassed Tyrode's solution at 37C. Cumulative concentration-response curves to carbachol or KCl were constructed. In other tissues the strips were stimulated electrically (1 to 40 Hz) with trains of square wave pulses 20 seconds in durati…

AgonistDetrusor muscleMalemedicine.medical_specialtyCarbacholmedicine.drug_classUrologyNeurokinin APig bladderMuscarinic Agonistsurologic and male genital diseasesMuscarinic agonistPotassium Chloridechemistry.chemical_compoundInternal medicineCulture TechniquesMuscle HypertoniamedicineHumansUrotheliumAgedDose-Response Relationship Drugurogenital systembusiness.industryTissue ExtractsMuscle SmoothMiddle Agedfemale genital diseases and pregnancy complicationsElectric StimulationStimulation ChemicalEndocrinologymedicine.anatomical_structurechemistryCarbacholFemaleNeurokinin Amedicine.symptomUrotheliumbusinessmedicine.drugMuscle contractionMuscle ContractionThe Journal of urology
researchProduct

Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells

1998

This paper deals with the apoptotic effect exerted in human retinoblastoma Y79 cells by a number of compounds. A remarkable effect was observed after treatment with DNA-damaging agents, such as camptothecin, etoposide, cisplatin and carboplatin; camptothecin was found to be the most efficacious. Treatment with these compounds induced the appearance of morphological features of apoptosis in the cells together with the distinct fragmentation of DNA, as shown by agarose gel electrophoresis. These effects were also accompanied by a remarkable increase in the level of p53. Many other compounds, which are not DNA-damaging agents, induced the morphological features of apoptosis but none of them we…

AmsacrinePaclitaxelDNA damageAntineoplastic AgentsApoptosisSuraminDNA ladderingBiologyretinoblastomaCarboplatinchemistry.chemical_compoundTumor Cells CulturedmedicineHumansFragmentation (cell biology)EtoposideCisplatinSodium butyrateGeneral MedicineAntineoplastic Agents PhytogenicMolecular biologyButyrateschemistryApoptosisAgarose gel electrophoresisImmunologyButyric AcidCamptothecinCisplatinDrug Screening Assays AntitumorCamptothecinDNA Damagemedicine.drug
researchProduct

Permeability of the rat bladder to Cisplatinum under different conditions: comparison with Mitomycin C and Adriamycin.

1983

In 50 female Sprague-Dawley rats the absorption of Cisplatinum through the bladder wall was studied. Under different conditions, including cystitis and electrocoagulation of the bladder mucosa, the absorption was low and the measureable serum concentrations did not exceed 2.64 micrograms/ml. The influence of Tween 80--a non-ionic surfactant--on the absorption is investigated. The results are compared with those found for Adriamycin and Mitomycin C under identical conditions.

Antibiotics AntineoplasticChemistryUrologymedicine.medical_treatmentMitomycinMitomycin CBladder MucosaUrinary BladderRats Inbred StrainsPharmacologySerum concentrationElectrocoagulationPermeabilityMitomycinsRatsPulmonary surfactantDoxorubicinAnesthesiaCystitismedicineElectrocoagulationAnimalsCisplatinRat BladderUrological research
researchProduct

Different muscarinic receptor subtypes modulate proliferation of primary human detrusor smooth muscle cells via Akt/PI3K and map kinases.

2013

While acetylcholine (ACh) and muscarinic receptors in the bladder are mainly known for their role in the regulation of smooth muscle contractility, in other tissues they are involved in tissue remodelling and promote cell growth and proliferation. In the present study we have used primary cultures of human detrusor smooth muscle cells (HDSMCs), in order to investigate the role of muscarinic receptors in HDSMC proliferation. Samples were obtained as discarded tissue from men >65 years undergoing radical cystectomy for bladder cancer and cut in pieces that were either immediately frozen or placed in culture medium for the cell culture establishment. HDSMCs were isolated from samples, propagat…

AtropineMalePyrrolidinesMessenger030232 urology & nephrologyGene ExpressionPhosphatidylinositol 3-Kinases0302 clinical medicineAged Atropine; pharmacology Benzofurans; pharmacology Carbachol; pharmacology Cell Proliferation Cells; Cultured Cholinergic Agonists; pharmacology Gene Expression Humans Male Mitogen-Activated Protein Kinases; metabolism Muscarinic Antagonists; pharmacology Myocytes; Smooth Muscle; metabolism Phosphatidylinositol 3-Kinases; metabolism Piperidines; pharmacology Pirenzepine; analogs /&/ derivatives/pharmacology Proto-Oncogene Proteins c-akt; metabolism Pyrrolidines; pharmacology RNA; Messenger; metabolism Receptors; Muscarinic; physiology Urinary Bladder; cytologyPiperidinesSmooth MuscleReceptorsMuscarinic acetylcholine receptor M5Muscarinic acetylcholine receptorCells CulturedCulturedMuscarinic acetylcholine receptor M3Muscarinic acetylcholine receptor M2Smooth muscle contractionMuscarinic acetylcholine receptor M1Receptors Muscarinic030220 oncology & carcinogenesisMitogen-Activated Protein KinasesAcetylcholinemedicine.drugmedicine.medical_specialtyCarbacholCellsMyocytes Smooth MuscleUrinary BladderMuscarinic AntagonistsBiologyCholinergic Agonists03 medical and health sciencesInternal medicineMuscarinicmedicineHumansRNA MessengerAgedBenzofuransCell ProliferationPharmacologyMyocytesPirenzepineEndocrinologyphysiologycytologyRNACarbacholanalogs /&/ derivatives/pharmacologymetabolismProto-Oncogene Proteins c-aktPharmacological research
researchProduct

MZ-35, a new layered pentasil borosilicate synthesized in the presence of large alkali cations

2013

Abstract A new layered borosilicate has been synthesized in the presence of cesium and sodium cations and its structure has been solved by a combination of automated diffraction tomography (ADT) and X-ray powder diffraction (XRPD). MZ-35 has a composition NaCs 2 [BSi 7 O 16 (OH) 2 ](OH) 2 ·4H 2 O and features space group P-4m2. The unusually small unit cell ( a 7.3081 A, c 10.7520 A) is shared by two random-stacked configurations of the structure: a network of connected pentasil units related to the layer of RUB-18 and a bidimensional checkerboard of intersecting ladders of 4-membered rings. The two configurations are related by the simple face-sharing inversion of a hydroxyl-bearing tetrah…

Automated electron diffraction tomography; Rietveld structure refinement; Layered borosilicate; 4-MR ladders; Face-sharing terahedraMaterials science4-MR laddersSodiumchemistry.chemical_element02 engineering and technology010402 general chemistry01 natural sciencesDiffraction tomographyFace-sharing terahedraGroup (periodic table)General Materials ScienceRietveld structure refinementLayered borosilicateBorosilicate glassAutomated electron diffraction tomographyGeneral Chemistry4-MR ladders; Automated electron diffraction tomography; Face-sharing terahedra; Layered borosilicate; Rietveld structure refinement[CHIM.MATE]Chemical Sciences/Material chemistry021001 nanoscience & nanotechnologyCondensed Matter PhysicsAlkali metal4-MR ladders; Automated electron diffraction tomography; Face-sharing terahedra; Layered borosilicate; Rietveld structure refinement;0104 chemical sciencesCrystallographychemistryMechanics of MaterialsCaesiumTetrahedron0210 nano-technologyPowder diffraction
researchProduct

Single dose prulifloxacina can improve BCG tollerability

2010

BCG bladder cancer prulifloxacin toxicitySettore MED/24 - Urologia
researchProduct

PATIENT’S COMPLIANCE TO BCG. DO WE ADEQUATELY CONSIDER IT?

2014

Introduction: Several studies and meta-analysis demonstrated that BCG is the best treatment for conservative management of high-risk NMI-BC with a net benefit in terms of both recurrence-free and progression-free survival (1, 2). Maintenance lasting minimum one year is recommended. In spite of the effectiveness, the amount of patients who complete the manteinance schedule does not exceed 50% (3). The reasons of BCG maintenance interruption remain still unclear. The aim of our study was to investigate the causes of low adherence to 1-year full dose maintenance BCG in a large series. Patients and Methods: The clinical files of consecutive patients affected by T1 HG NMI-BC and undergoing adjuv…

BCG intravesical therapy bladder cancerSettore MED/24 - Urologia
researchProduct